Bridgewater Associates’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$812K Sell
39,556
-109,701
-73% -$2.51M ﹤0.01% 862
2026
Q1
$3.29M Sell
149,257
-99,925
-40% -$1.74M 0.01% 524
2025
Q4
$2.94M Sell
249,182
-20,429
-8% -$262K 0.01% 675
2025
Q3
$4.27M Buy
+269,611
New +$3.91M 0.02% 526
2024
Q3
– Sell
-103,654
Closed -$2.34M – 795
2024
Q2
$2.34M Sell
103,654
-136,461
-57% -$3.57M 0.01% 502
2024
Q1
$6.31M Buy
240,115
+61,396
+34% +$1.75M 0.03% 339
2023
Q4
$5.64M Sell
178,719
-80,216
-31% -$2.18M 0.03% 350
2023
Q3
$7.26M Buy
258,935
+189,456
+273% +$6.5M 0.04% 289
2023
Q2
$2.56M Buy
69,479
+7,131
+11% +$218K 0.02% 430
2023
Q1
$1.87M Sell
62,348
-56,951
-48% -$1.88M 0.01% 468
2022
Q4
$3.65M Buy
+119,299
New +$3.58M 0.02% 421
2022
Q2
– Sell
-34,393
Closed -$1.08M – 1003
2022
Q1
$1.08M Buy
+34,393
New +$1.08M ﹤0.01% 790
2021
Q1
– Sell
-20,277
Closed -$503K – 480
2020
Q4
$503K Buy
20,277
+3,871
+24% +$92.1K ﹤0.01% 462
2020
Q3
$343K Buy
+16,406
New +$317K ﹤0.01% 419

Other funds holding CC

Bridgewater Associates's CC Position: Q2 2026 in Review

Bridgewater Associates reduced its Chemours (CC) stake by 73% in Q2 2026, selling an estimated $2.51M and leaving 39,556 shares worth $812K. The position accounts for ﹤0.01% of the portfolio, ranked #862.

Bridgewater Associates first reported a position in CC in Q3 2020 and has held it in 14 quarters since. The position peaked at $7.26M in Q3 2023. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Bridgewater Associates held 39,556 shares of Chemours worth $812K as of Q2 2026.
  • Bridgewater Associates sold 109,701 Chemours shares in Q2 2026, an estimated $2.51M.
  • Chemours made up ﹤0.01% of Bridgewater Associates's portfolio in Q2 2026, its #862 holding.
  • Bridgewater Associates first reported a position in Chemours in Q3 2020 and has held it in 14 quarters since.
  • Bridgewater Associates's Chemours position peaked at $7.26M in Q3 2023.
  • 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.